Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup

HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful of ...
MMA Mania on MSN

PFL Lyon live streaming results, highlights | 'Nemkov vs. Ferreira'

Professional Fighters League (PFL) is set to touch down in Lyon, France later TODAY (Sat., Dec. 13, 2025) to stage PFL Lyon ...

Mineralys Therapeutics, Inc.: Mineralys Therapeutics' Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA ...

HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful ...
CounterfireOpinion

Just Stop Oil’s Record is Complicated

As JSO’s successor organisation, Take Back Power, launches, it is time to reflect seriously on the achievements and ...
SINGPromos

Seven heartland countdown celebrations organised by People’s Association on 31 Dec 2025

People’s Association’s Seven Heartland Countdown Celebrations Bring Communities Together to Welcome 2026 ...